BCWM
REGN icon

Bartlett & Co Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bartlett & Co Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Buy
362
+1
+0.3% +$766 ﹤0.01% 419
2025
Q4 		$279K Hold
361
– – ﹤0.01% 413
2025
Q3 		$203K Buy
361
+14
+4% +$7.92K ﹤0.01% 446
2025
Q2 		$182K Buy
347
+3
+0.9% +$1.67K ﹤0.01% 458
2025
Q1 		$218K Hold
344
– – ﹤0.01% 435
2024
Q4 		$245K Hold
344
– – ﹤0.01% 413
2024
Q3 		$362K Hold
344
– – 0.01% 372
2024
Q2 		$362K Sell
344
-2
-0.6% -$1.94K 0.01% 364
2024
Q1 		$333K Buy
346
+2
+0.6% +$1.9K 0.01% 387
2023
Q4 		$303K Hold
344
– – ﹤0.01% 413
2023
Q3 		$283K Hold
344
– – 0.01% 406
2023
Q2 		$247K Hold
344
– – ﹤0.01% 426
2023
Q1 		$283K Hold
344
– – 0.01% 347
2022
Q4 		$248K Hold
344
– – 0.01% 354
2022
Q3 		$237K Hold
344
– – 0.01% 351
2022
Q2 		$203K Hold
344
– – ﹤0.01% 370
2022
Q1 		$240K Hold
344
– – ﹤0.01% 365
2021
Q4 		$217K Hold
344
– – ﹤0.01% 381
2021
Q3 		$208K Sell
344
-9
-3% -$5.59K ﹤0.01% 331
2021
Q2 		$197K Hold
353
– – ﹤0.01% 333
2021
Q1 		$167K Hold
353
– – ﹤0.01% 344
2020
Q4 		$171K Buy
353
+9
+3% +$4.86K ﹤0.01% 341
2020
Q3 		$193K Hold
344
– – ﹤0.01% 313
2020
Q2 		$215K Buy
344
+135
+65% +$76.6K 0.01% 303
2020
Q1 		$102K Hold
209
– – ﹤0.01% 367
2019
Q4 		$78.5K Hold
209
– – ﹤0.01% 441
2019
Q3 		$58K Buy
209
+168
+410% +$49.7K ﹤0.01% 503
2019
Q2 		$12.8K Buy
41
+1
+3% +$333 ﹤0.01% 571
2019
Q1 		$16.4K Hold
40
– – ﹤0.01% 536
2018
Q4 		$14.9K Hold
40
– – ﹤0.01% 543
2018
Q3 		$16.2K Hold
40
– – ﹤0.01% 561
2018
Q2 		$13.8K Hold
40
– – ﹤0.01% 569
2018
Q1 		$13.8K Buy
+40
New +$13.9K ﹤0.01% 577

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bartlett & Co Wealth Management's REGN Position: Q1 2026 in Review

Bartlett & Co Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.28% in Q1 2026, buying an estimated $766 and bringing the position to 362 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

Bartlett & Co Wealth Management first reported a position in REGN in Q1 2018 and has held it in 33 quarters since. The position peaked at $362K in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Bartlett & Co Wealth Management held 362 shares of Regeneron Pharmaceuticals worth $257K as of Q1 2026.
  • Bartlett & Co Wealth Management bought 1 Regeneron Pharmaceuticals share in Q1 2026, an estimated $766.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #419 holding.
  • Bartlett & Co Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 33 quarters since.
  • Bartlett & Co Wealth Management's Regeneron Pharmaceuticals position peaked at $362K in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.